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Men and sharks are both jawed vertebrates at the top of the food chain. Sharks are the
first extant to develop adaptive immunity preserved to man throughout jawed vertebrates.
We hypothesize here, that T cell receptor/major histocompatibility complex (TCR/MHC)
interactions developed as the defense mechanism of carnivors against takeover by their
victims’ cells derived pathogens. Germline encoded TCR segments have been conserved
in evolution, providing the MHC bias of TCR. Ancestor genes of MHC polymorphisms
may have first developed as a mating preference system, that later in evolution provided
host immune responses destroying infectious non-self, yet maintaining tolerance to self.
Pathogens may thus have simultaneously selected for alloimmunity. Allorejection has been
observed in sharks and men. Cannibalism is a common ecological interaction in the animal
kingdom, especially prevalent in aquatic communities; it favors selection of intraspecies
allo responses for defense of self integrity. Alloreactive T cells do not undergo negative
selection of strong TCR/MHC interactions; thus, they react stronger than self-MHC recog-
nizingT cells. High levels of genetic diversity at MHC genes play a critical role in protecting
populations of vertebrate species from contagious cells displaying stemness and homing
features, including cancer cells. Recognition of self-MHC fails especially in diseases, which
predominantly arise with age and after the peak of reproduction, e.g., cancer. So far, the
treatment of malignant disease with autologous T cells has widely failed. Allorecognition
constitutes an extremely powerful mechanism in evolution, which may be employed in
immunotherapy of cancer by MHC-disparate, e.g., haploidentical transplantation and con-
secutive treatment withT cells from the donor parents recognizing tumor selective peptides
presented by the non-inherited haplotype on the tumor.
Keywords: allorestrictedT cells, immunotherapy of cancer, haploidentical transplantation, tumor therapy, cellular
immunity, adaptive immunity,TCR/MHC evolution
WHAT DO MEN AND SHARKS HAVE IN COMMON?
They are both jawed vertebrates and at the top of the food
chain. Sharks have achieved this by the most powerful jaws
on the planet. They were the first big meat eaters (carni-
vores) in evolution. Because the sharks’ teeth are replaceable,
they may grow. Sharks may use over 20,000 teeth in its life-
time (Rafferty, 2011). Thus, they represent the paradigm of
gnathostomata (jawed vertebrates). It is obvious why these
first big meat eaters in evolution were jawed, but why were
the first meat eaters also the first to develop adaptive immu-
nity in the animal kingdom? And what may men learn from
sharks?
In essence, we hypothesize here, that T cell recep-
tor/major histocompatibility complex (TCR/MHC) interactions
developed as the defense mechanism of carnivors against
takeover by their victims’ cells or merely the pathogens these
cells may carry. Thus, TCR/MHC interaction represents an
extremely powerful mechanism in evolution. Such success-
ful mechanisms are to be employed in immunotherapy of
cancer.
JAWED VERTEBRATES WERE FIRST CARNIVORS,
DISCRIMINATING SELF AND NON-SELF BY ADAPTIVE
CELLULAR IMMUNITY BYMEANS OF V(D)J RECOMBINATION
Herein, cognate recognition of auto- as well as allo-MHC is critical.
Germline encoded TCR segments have been selected by evolu-
tion to promote recognition of MHC, i.e., the MHC bias of TCR
(Scott-Browne et al., 2011). This may be the reason why, T cell
receptor V(D)J recombination-based auto and allo-MHC recog-
nition first evolved in the earliest gnathostomata rays and shark
450 million years ago (Litman et al., 2010) in an evolutionary
time span estimated to be less than 20 million years (Marchalo-
nis and Schluter, 1998). These huge carnivors were exposed to a
tremendous increase in pathogen exposure necessitating the devel-
opment of versatile recognition systems discriminating between
pathogen containing and non-containing cells. Allo and auto-
MHC recognition are both based on the inherent MHC bias of
the TCR.
V(D)J recombination-based MHC recognition occurred by a
horizontal transposon insertion of bacterial genes into the ver-
tebrate genome (Agrawal et al., 1998). This insertion placed the
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recombinase activating genes RAG1 and RAG2 into an already
existing non-rearranging V-like exon of an Ig-domain-containing
gene that was regulating cell mediated cytotoxicity or phagocyto-
sis (Kaufman, 2002; Van Den Berg et al., 2004). The result was a
method of rearranging genes to create molecules that had a greater
structural diversity than those supplied by the genome for the rest
of the vertebrate body. This event for these reasons is so radical
and unprecedented that it has been described as a biological “Big
Bang” (Schluter et al., 1999). While there has been evolutionary
modifications in mammals, even the most basal group of living
gnathostomes, the elasmobranchii or cartilaginous fish, contain
all its basic elements: MHC class I and class II, Ig, TCR chains α, β,
γ, and δ (Rast et al., 1997), and RAG1 and RAG2 (Agrawal et al.,
1998; Laird et al., 2000). In spite of extensive search, none of these
elements have been found in the phylogenically earlier agnathia
(such as lampreys and hagfish) (Roitt et al., 1998; Mayer et al.,
2002; Flajnik and Du Pasquier, 2008).
However, there is no evidence that the MHC is derived directly
from allorecognition systems occurring earlier in evolution in
plants and invertebrates. Such previous allorecognition systems,
such as FuHC (fusion/histocompatibility) in the urochordate
Botryllus function to defend the genetic integrity of the individ-
ual by preventing intraspecific stem cell parasitism as well as
self-fertilization and inbreeding (Laird et al., 2005). There is no
evidence that these allorecognition systems are ancestors of MHC.
Rather, based on the synteny to olfactorial polymorphisms,
it has been assumed, that MHC polymorphisms may have devel-
oped as a mating preference system (Potts et al., 1991). In addition,
infectious agents selected for host immune responses that destroy
infectious non-self, yet maintain tolerance to self. Retroviruses
and other pathogens may thus have simultaneously selected for
alloimmunity (Gould et al., 2004), because polymorphism was
primarily advantageous to the population and maybe secondary
advantageous to the genetic integrity of the individual by providing
allorecognition and allorejection.
WHAT CAME FIRST: ALLOREACTIVITY OR THE
“CONVENTIONAL IMMUNE RESPONSE” DIRECTED AGAINST
PEPTIDES PRESENTED BY SELF-MHC?
To answer this question, it may be helpful to compare MHC
and TCR variability: Precedence of MHC variability before TCR
variability, would argue in favor of peptide recognition and the
conventional immune response. In contrast, precedence of TCR
variability before MHC variability would argue in favor of allo-
MHC reactivity. In that case, invariant MHC would have been too
primitive for versatile peptide binding. Kurosawa and Hashimoto
(1997) argues that MHC variability came in before TCR variabil-
ity, i.e., first, there was only one TCR. These assumptions are based
on the postulate, that allorecognition is MHC dominant. However
there is also evidence that allorecognition may be peptide domi-
nant (Felix and Allen, 2007). Moreover, the recent discovery, that
a single amino acid in the TCR CDR2 is conserved from shark to
man and is critical for MHC recognition by TCR (Scott-Browne
et al., 2011) would argue in favor of MHC recognition before pep-
tide recognition. This finding underlines Nils Jerne’s postulate of a
germ line encoded, innate MHC bias of the random TCR repertoire,
located in MHC binding CDR1 and CDR2. Nevertheless, sharks
do have a thymus and are capable of peptide selection (Roitt et al.,
1998). However, γ/δ TCR is capable of recognizing antigen inde-
pendent of MHC and is likely to have preceded α/β TCR. We
conclude, that based on the inherent TCR/MHC affinity, these
two systems have developed simultaneously (Table 1).
Allorejection has been observed in the rudimentary from of
chronic graft rejection in elamosbranchs, including sharks (Kuro-
sawa and Hashimoto, 1997). Allorejection has been observed in
sharks and men, although it is not restricted to gnathostomata.
However, allorecognition by adaptive cellular immunity by means
of V(D)J recombination is restricted to gnathostomata. Thus, allo-
MHC recognition may be essential in carnivorous vertebrates for
self defense (Figure 1).
Of interest, while mechanisms of adaptive immunity are con-
served in evolution from sharks to men, innate immunity displays
great interspecies variation of mechanisms, although T and NK
cells have both common ancestors and a common way to kill
(granzyme/perforin). γ/δ T cells may bridge adaptive and innate
immunity by combining adaptive features independent of MHC
with rapid, innate-like responses (Vantourout and Hayday, 2013).
ALLOREACTIVITY AND THE SCHWABING CARNIVOR
HYPOTHESIS OF SUPERIORITY OF MHC ALLORESTRICTED T
CELLS IN IMMUNOTHERAPY OF CANCER
Hitherto, the selective pressure for allorecognition has remained even
more of an enigma for the scientific community than the mecha-
nism allorecognition itself (Felix and Allen, 2007). Allorecognition
has drawn the attention of immunologists in the context of trans-
plantation, a relatively new phenomenon in evolution, not able
to display selective pressure. However, devouring of raw meat of
the same species containing viruses and other parasites represents
a selective pressure for MHC recognition and the development of
allorejection. Since agnathan shark prey such as lamprey and hag-
fish did not display MHC, selective pressure for allorecognition
to defend individual genetic integrity occurred first, when sharks
started eating sharks: cannibalism became a constitutive feature
of this extant, but not restricted to it. In zoology, cannibalism is
Table 1 |The Schwabing Carnivor Hypothesis of Superiority of MHC
allorestrictedT cells in Immunotherapy of Cancer.
MHC polymorphisms may have first developed as a mating preference
system, that later in evolution provided host immune responses destroying
infectious non-self, yet maintaining tolerance to self
Pathogens may thus have simultaneously selected for alloimmunity
Alloreactive T cells do not undergo negative selection of strong TCR/MHC
interactions; thus, they react stronger than self-MHC recognizing T cells
So far, the treatment of malignant disease with autologous T cells has
widely failed
Allorecognition constitutes an extremely powerful mechanism in evolution,
which may be employed in immunotherapy of cancer
Haploidentical transplantation and consecutive treatment with T cells from
the donor parents recognize tumor selective peptides presented by the
non-donor parent haplotype on the tumor
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FIGURE 1 | (A,B) Allorecognition by adaptive cellular immunity by means of
V(D)J recombination is restricted to gnathostomata. Allo-MHC recognition
may be essential in carnivorous vertebrates for self defense. Devouring of
raw meat of the same species containing viruses and other parasites
represents a selective pressure for MHC recognition and the development
of allorejection. Since agnathan shark prey such as lamprey and hagfish did
not display MHC, selective pressure for allorecognition to defend individual
genetic integrity occurred first, when sharks started eating sharks:
cannibalism became a constitutive feature of this extant. (C) A single amino
acid in the TCR CDR2 (red), conserved from shark to man and critical for
MHC recognition (green) by TCR argues in favor of MHC recognition before
peptide recognition and underlines the postulate of a germ line encoded,
innate MHC bias of the random TCR repertoire, located in MHC binding
CDR1 and CDR2.
a common ecological interaction in the animal kingdom and has
been recorded for more than 1500 species (Polis, 1981). It com-
monly occurs under natural conditions in a variety of species,
including man (Elgar and Crespi, 1992) Cannibalism seems to
be especially prevalent in aquatic communities, in which up to
approximately 90% of the organisms engage in cannibalism at
some point of the life cycle (Fox, 1975). Injuries violating epi-
dermal and mucosal barriers during shark fights with ensuing
cannibalism may have facilitated chimerism. Thus, it is not com-
pletely clear weather defense against prey derived pathogens alone
or the prey itself as well was the driving force of development of
adaptive immunity (Marchalonis and Schluter, 1998; Klimovich,
2002; Marchalonis et al., 2002). The consideration, that “there is
a growing tendency to regard the evolutionary origin of adap-
tive immunity as being related to something other than defense
against pathogenic microorganisms”has been attributed to Burnet
himself (Rinkevich, 2004). Rationales of its development include
the defense of host integrity against cells from the same or other
species, and that it aided the management of symbiosis with
commensals (Klimovich, 2002; McFall-Ngai, 2002).
Cellular adaptive immunity probably preceded humoral adap-
tive immunity in evolution (Parham, 1992). In jawless vertebrates
(agnathia), e.g., lamprey and hagfish, leucine-rich repeat variants
(LRR) function as variable lymphoid receptors (VLR), the fore-
runners of T cell receptors and immunoglobulins (Rast et al.,
1997). Adaptive cellular immunity based on V(D)J recombination
and MHC recognition developed, according to our reasoning, first
to protect the carnivor organism from foreign invasion by takeover
by the cells of the victims of its cannibalism and/or from infection
by the viruses, the devoured cells contained. Consecutively, the
recognition of self-MHC by V(D)J recombination-based adaptive
immunity may have developed simultaneously with allorecogni-
tion, both as critical mechanisms for defense of the biological ego
against infection and non-self. In fact, alloreactivity has muchmore
in common with the conventional immune response than previously
thought.
Since alloreactive T cells did not undergo negative selection of
strong TCR/MHC interactions, they react stronger than self-MHC
recognizing T cells. Another hallmark of alloreactivity is the high
precursor frequency of alloreactive T cells, which is 100-fold to
1,000-fold higher than the precursor frequency of T cells specific
for any single foreign-peptide–self-MHC complex (Lindahl and
Wilson, 1977). The high frequency of alloreactive T cells (1 in 103–
104) enables their detection during a primary immune response, a
defining feature of alloreactivity (Felix and Allen, 2007). Given the
high frequency of alloreactive T cells may be of importance, as well,
for immunotherapy with transgenic allorestricted T cells, since this
population constitutes the target population of the transgene.
The importance of alloreactivity for protection against non-self is
illustrated, e.g., by a transplantable tumor in the Tasmanian devil, a
large carnivorous Australian marsupial. Transmission of this fatal
clonal tumor by biting occurs due to depleted MHC diversity and
threatens the devil with extinction (Siddle et al., 2007). High levels
of genetic diversity at MHC genes play a critical role in protect-
ing populations of vertebrate species from contagious cancer, of
which two forms do exist, which are either transmitted by bit-
ing (as in the Devil Facial Tumor Disease, DFTD) or by sexual
contact (as in case of the Canine Transmissible Venereal Tumor,
CTVT, e.g., in Bernadine dogs) (Mello Martins et al., 2005). Species
that have undergone genetic bottlenecks and have lost diversity at
MHC genes are at risk of transmissible tumors. Moreover, evo-
lution and selection for tumor variants capable of evading the
immune response allow contagious cancers to cross MHC barri-
ers (Belov, 2011). This could also apply to other cells displaying
stemness and homing features after being devoured by carnivores
(Table 1).
In contrast to allorecognition, recognition of auto-MHC is not
triggering effective T cell responses in all situations, given the
risks of autoimmunity. Auto-MHC responses fail especially in
diseases, whose elimination is evolutionary not imperative, e.g.,
cancer. We perceive the co-evolution of tumor and host imprinted
immuno-editing as the general cause of the failure of immune
surveillance of cancer, yielding escape of the tumor from immune
surveillance.
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Thus far, the treatment of malignant disease with autologous
T cells has been effective only in part ; although a plethora of
approaches has been developed including activation of the anti-
tumor response through vaccination, promoting T cell function
by leadfooting their accelerators and turning off their brakes,
expanding existing tumor reactive T cells by adoptive T cell ther-
apy, redirecting T cells utilizing TCR transduction, e.g., chimeric
antigen receptor (CAR) engineering (Gao et al., 2013). Most
advanced results are being seen in melanomas for the former
(Restifo et al., 2012) and some in chronic lymphocytic leukemia
and myeloma for the latter, i.e., the CAR approach (Maus and
June, 2013). These advances may well be complemented and
lead into a new dimension by employment of allorestricted T
cells. The success of allo-MHC recognition by adaptive immu-
nity both in terms of the evolutionary success of the defense
of the biological ego in carnivorous vertebrates, as well as with
respect to allorejection in MHC-disparate organ transplanta-
tion, constitutes a rationale for employment of alloreactive T
cells in antineoplastic immunotherapy (Stauss, 1999) not only in
hematopoietic malignancies (Kolb et al., 1990) but also in other
mesenchymal neoplasias, such as sarcomas (Burdach et al., 2000)
(Figure 1).
CONCLUSION
In essence we postulate here, that TCR/MHC interactions devel-
oped as a defense mechanism of gnathostomata against takeover
by their victims’ cells and/or their deleterious viral load. Allorecog-
nition constitutes an extremely powerful mechanism in evo-
lution, which may be employed in immunotherapy of cancer
by e.g., haploidentical transplantation and consecutive treat-
ment with T cells from the donor parents recognizing tumor
selective peptides presented by the non-donor parent haplo-
type on the tumor. In addition, the application of alloreactivity,
can be extended to mismatched unrelated transplants including
umbilical cord blood transplants. Taken together, T cell reactiv-
ity toward allo-MHC, i.e., to inherited non-donor MHC alle-
les, can be advantageous in cancer therapy. This assumption
may be dubbed the Schwabing Carnivor Hypothesis of Superi-
ority of MHC allorestricted T cells in Immunotherapy of Cancer
(SCHySM).
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